Vascular Calcification
44
3
4
27
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 44 trials
100.0%
+13.5% vs benchmark
23%
10 trials in Phase 3/4
15%
4 of 27 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 27 completed trials
Clinical Trials (44)
Effect of Citrate Dialysate on Vascular Calcification
Mammography and Breast Arterial Calcification: An Information-Sharing Trial
Comparison of RA-IVL and RA-SHP in Calcified Coronary Lesions
Immunomodulatory Effects of PCSK9 Inhibition
Analysis of the Influence of Dialysis Fluid Composition on Vascular Calcification in Patients With Chronic Kidney Disease Undergoing Hemodialysis
GUIDE-CAC: Statin-Ezetimibe Without Aspirin vs. Statin Monotherapy With Aspirin in High Coronary Calcification
Pentoxifylline for Vascular Calcification in Kidney Disease
Potential Cross-Talk Between Arterial Calcifications
Impact of Parathyroidectomy on Cardiovascular Calcification in Dialysis-dependent Patients
Calcium Reduction by Orbital Atherectomy in Western Europe
The Effect of Etelcalcetide on CKD-MBD
Orbital Vessel PreparaTIon to MaximIZe Dcb Efficacy in Calcified Below the Knee (BTK) Lesions - A Pilot Study
Observer Variability in Scoring Abdominal Aortic Calcifications and Vertebral Morphometry
Use of Discarded Surgery Human Tissue Specimens for Basic Science Research
Treatment to Reduce Vascular Calcification in Hemodialysis Patients Using Vitamin K
Effect of Oral Magnesium on Vascular Calcification in Chronic Kidney Disease
Aortic Calcification and Central Blood Pressure in Patients With Chronic Kidney Disease
Pilot Medical Evaluation of the T50 Test
Vitamin k1 and Its Relation to Vascular Calcification in Hemodialysis Patients
Coronary Artery Calcification in Type 2 Diabetes Mellitus (USCAC Study)